-
Reliance Industr
1,288.00 1,115.55(%) -
ITC
423.35 381.24(%) -
Trent
5,106.40 4,058.45(%) -
Hind. Unilever
2,339.45 3,034.50(%) -
Larsen & Toubro
3,231.30 2,967.65(%) -
Asian Paints
2,413.50 2,125.00(%) -
Ambuja Cements
544.50 452.90(%) -
Atul
6,566.00 8,165.25(%) -
ACC
1,930.00 1,778.80(%) -
Reliance Infra.
250.50 143.70(%) -
M & M
2,831.30 2,001.00(%) -
Hind.Construct.
25.51 21.37(%) -
MRF
127,450.00 100,500.00(%) -
Nestle India
2,387.80 2,115.00(%) -
PCBL Chemical
379.15 208.80(%) -
Hindalco Inds.
612.90 546.25(%) -
Force Motors
8,860.00 6,128.55(%) -
Indian Hotels Co
770.20 507.45(%) -
Kirl.Pneumatic
1,144.70 790.15(%) -
Exide Inds.
367.05 327.95(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Lupin Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 3026.0
- ISIN : INE326A01037
-
Today’s Low
2,011.20 -
Today’s High
2,124.90

-
Open
2,110.80 -
Perv Close
2,104.10 -
52W Low
0.00 -
52W High
0.00
Key Indicators
-
P/E(TTM)
29.46
-
Mar.Cap (₹Cr.)
92,207.88
-
Div & Yield %
0.40
-
Book Value(₹)
481.38
-
Debt-Equity Ratio
-4.02
-
AGM Date
25-Apr-2025
-
EPS
68.52
-
P/E Ratio
29.46
Financials Ratios
-
Debt-Equity Ratio
0.28
-
Mar.Cap (₹Cr.)
92,207.88
-
RONW (%)
14.47
-
ROCE (%)
15.34
Score Board
-
Equity (₹ in Cr.)
91.31
-
BV (₹)
481.40
-
Sales( ₹ in Cr.)
14,666.50
-
NP (in Cr.)
2,302.84
-
NP Var(%)
461.0
-
Div%
400.0
-
CPS (₹)
66.30
-
EPS (₹)
50.40
-
Traded Value (₹ in Lakhs)
96,102.38
-
52 Week High
0.00
-
52 Week Low
0.00
-
Price BSE
2105.0
-
Price NSE
2,104.00
-
Market Capital( in Cr.)
96,102.38
-
P/C Ratio
31.70
-
P/E Ratio
41.70
-
Price Vs.BV
50.40
-
24-Apr-2025( 11:40)
Hot Pursuit - Lupin... - The drug is bioequivalent to J...
-
24-Apr-2025( 11:06)
Corporate News - Lupin... - <P> Lupin has received ap...
-
17-Apr-2025( 03:00)
Hot Pursuit - Lupin... - The EIR was issued following a...
-
21-Mar-2025( 07:12)
Corporate News - Nanom... - <P>Nanomi B.V., a Dutch subsid...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 14,666.50 | 11,258.83 | 11,771.67 | 11,055.93 | 11,025.66 | 11,356.32 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 14,666.50 | 11,258.83 | 11,771.67 | 11,055.93 | 11,025.66 | 11,356.32 |
Other Income | 115.51 | 210.02 | 216.99 | 129.09 | 475.19 | 291.34 |
Stock Adjustments | 15.93 | -120.79 | 242.38 | 81.86 | 28.72 | 147.23 |
Total Income | 14,797.94 | 11,348.06 | 12,231.04 | 11,266.88 | 11,529.57 | 11,794.89 |
EXPENDITURE : | ||||||
Raw Materials | 5,041.16 | 4,676.90 | 4,709.64 | 4,264.17 | 4,235.99 | 4,040.13 |
Power and Fuel Cost | 444.41 | 447.42 | 418.45 | 389.54 | 416.26 | 416.30 |
Employee Cost | 2,095.51 | 1,934.14 | 1,918.16 | 1,695.86 | 1,703.22 | 1,515.42 |
Other Manufacturing Expenses | 1,182.52 | 1,155.60 | 1,209.09 | 1,135.79 | 1,108.70 | 1,050.87 |
Selling and Administration Expenses | 2,268.24 | 1,797.13 | 1,573.22 | 1,355.01 | 1,557.70 | 1,488.58 |
Miscellaneous Expenses | 200.31 | 162.95 | 1,976.35 | 253.36 | 884.11 | 479.45 |
Employee Benefit Expenses | 2,095.51 | 1,934.14 | 1,918.16 | 1,695.86 | 1,703.22 | 1,515.42 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 11,232.15 | 10,174.14 | 11,804.91 | 9,093.73 | 9,905.98 | 8,990.75 |
Operating Profit | 3,565.79 | 1,173.92 | 426.13 | 2,173.15 | 1,623.59 | 2,804.14 |
Interest | 56.35 | 98.44 | 73.47 | 40.62 | 52.59 | 35.47 |
Gross Profit | 3,509.44 | 1,075.48 | 352.66 | 2,132.53 | 1,571.00 | 2,768.67 |
Depreciation | 724.75 | 548.34 | 514.19 | 502.83 | 518.75 | 426.30 |
Profit Before Tax | 2,784.69 | 527.14 | -161.53 | 1,629.70 | 1,052.25 | 2,342.37 |
Current Tax | 484.05 | 95.89 | 57.80 | 362.85 | 362.05 | 795.00 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -25.45 | 6.04 | -30.63 | 8.23 | -37.35 | 8.54 |
Reported Net Profit | 2,326.09 | 425.21 | -188.70 | 1,258.62 | 727.55 | 1,538.83 |
Extraordinary Items | 23.25 | 14.42 | 30.64 | 41.61 | -425.63 | -205.15 |
Adjusted Net Profit | 2,302.84 | 410.79 | -219.34 | 1,217.01 | 1,153.18 | 1,743.98 |
Adjustment below Net Profit | -8.79 | -1.39 | 2.42 | -7.89 | -135.66 | -46.47 |
P & L Balance brought forward | 15,274.71 | 15,032.74 | 15,514.10 | 14,535.25 | 14,227.34 | 12,961.06 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 258.04 | 181.85 | 295.08 | 271.88 | 226.30 | 226.08 |
P & L Balance carried down | 17,333.97 | 15,274.71 | 15,032.74 | 15,514.10 | 14,592.93 | 14,227.34 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 400.00 | 200.00 | 200.00 | 325.00 | 300.00 | 250.00 |
Dividend Per Share(Rs) | 8.00 | 4.00 | 4.00 | 6.50 | 6.00 | 5.00 |
Earnings Per Share-Unit Curr | 51.04 | 9.35 | -4.15 | 27.74 | 16.06 | 34.01 |
Earnings Per Share(Adj)-Unit Curr | 51.04 | 9.35 | -4.15 | 27.74 | 16.06 | 34.01 |
Book Value | 452.12 | 404.66 | 399.34 | 409.20 | 385.72 | 378.28 |
Book Value(Adj)-Unit Curr | 452.12 | 404.66 | 399.34 | 409.20 | 385.72 | 378.28 |